Ethical Justifications for Access to Unapproved Medical Interventions

An Argument for (Limited) Patient Obligations

Mary Jean Walker*, Wendy A. Rogers, Vikki Entwistle

*Corresponding author for this work

Research output: Contribution to journalArticle

29 Citations (Scopus)
4 Downloads (Pure)

Abstract

Many health care systems include programs that allow patients in exceptional circumstances to access medical interventions of as yet unproven benefit. In this article we consider the ethical justifications for-and demands on-these special access programs (SAPs). SAPs have a compassionate basis: They give patients with limited options the opportunity to try interventions that are not yet approved by standard regulatory processes. But while they signal that health care systems can and will respond to individual suffering, SAPs have several disadvantages, including the potential to undermine regulatory and knowledge-generation structures that constitute significant public goods. The "balance" between these considerations depends in part on how broadly SAPs are used, but also on whether SAPs can be made to contribute to the generation of knowledge about the effects of health interventions. We argue that patients should usually be required to contribute outcome data while using SAPs.

Original languageEnglish
Pages (from-to)3-15
Number of pages13
JournalAmerican Journal of Bioethics
Volume14
Issue number11
DOIs
Publication statusPublished - 17 Oct 2014

Keywords

  • special access
  • patient rights
  • health care delivery
  • regulatory issues
  • experimental therapies
  • research ethics
  • end-of-life issues
  • terminally-ill patients
  • therapeutic misconception
  • compassionate use
  • health-care
  • off-label
  • drugs
  • discovery
  • agents

Cite this

Ethical Justifications for Access to Unapproved Medical Interventions : An Argument for (Limited) Patient Obligations. / Walker, Mary Jean; Rogers, Wendy A.; Entwistle, Vikki.

In: American Journal of Bioethics, Vol. 14, No. 11, 17.10.2014, p. 3-15.

Research output: Contribution to journalArticle

Walker, Mary Jean ; Rogers, Wendy A. ; Entwistle, Vikki. / Ethical Justifications for Access to Unapproved Medical Interventions : An Argument for (Limited) Patient Obligations. In: American Journal of Bioethics. 2014 ; Vol. 14, No. 11. pp. 3-15.
@article{6fb8064b7aad4e93a55dcc893986cc0a,
title = "Ethical Justifications for Access to Unapproved Medical Interventions: An Argument for (Limited) Patient Obligations",
abstract = "Many health care systems include programs that allow patients in exceptional circumstances to access medical interventions of as yet unproven benefit. In this article we consider the ethical justifications for-and demands on-these special access programs (SAPs). SAPs have a compassionate basis: They give patients with limited options the opportunity to try interventions that are not yet approved by standard regulatory processes. But while they signal that health care systems can and will respond to individual suffering, SAPs have several disadvantages, including the potential to undermine regulatory and knowledge-generation structures that constitute significant public goods. The {"}balance{"} between these considerations depends in part on how broadly SAPs are used, but also on whether SAPs can be made to contribute to the generation of knowledge about the effects of health interventions. We argue that patients should usually be required to contribute outcome data while using SAPs.",
keywords = "special access, patient rights, health care delivery, regulatory issues, experimental therapies, research ethics, end-of-life issues, terminally-ill patients, therapeutic misconception, compassionate use , health-care, off-label, drugs, discovery, agents",
author = "Walker, {Mary Jean} and Rogers, {Wendy A.} and Vikki Entwistle",
year = "2014",
month = "10",
day = "17",
doi = "10.1080/15265161.2014.957416",
language = "English",
volume = "14",
pages = "3--15",
journal = "American Journal of Bioethics",
issn = "1526-5161",
publisher = "Routledge",
number = "11",

}

TY - JOUR

T1 - Ethical Justifications for Access to Unapproved Medical Interventions

T2 - An Argument for (Limited) Patient Obligations

AU - Walker, Mary Jean

AU - Rogers, Wendy A.

AU - Entwistle, Vikki

PY - 2014/10/17

Y1 - 2014/10/17

N2 - Many health care systems include programs that allow patients in exceptional circumstances to access medical interventions of as yet unproven benefit. In this article we consider the ethical justifications for-and demands on-these special access programs (SAPs). SAPs have a compassionate basis: They give patients with limited options the opportunity to try interventions that are not yet approved by standard regulatory processes. But while they signal that health care systems can and will respond to individual suffering, SAPs have several disadvantages, including the potential to undermine regulatory and knowledge-generation structures that constitute significant public goods. The "balance" between these considerations depends in part on how broadly SAPs are used, but also on whether SAPs can be made to contribute to the generation of knowledge about the effects of health interventions. We argue that patients should usually be required to contribute outcome data while using SAPs.

AB - Many health care systems include programs that allow patients in exceptional circumstances to access medical interventions of as yet unproven benefit. In this article we consider the ethical justifications for-and demands on-these special access programs (SAPs). SAPs have a compassionate basis: They give patients with limited options the opportunity to try interventions that are not yet approved by standard regulatory processes. But while they signal that health care systems can and will respond to individual suffering, SAPs have several disadvantages, including the potential to undermine regulatory and knowledge-generation structures that constitute significant public goods. The "balance" between these considerations depends in part on how broadly SAPs are used, but also on whether SAPs can be made to contribute to the generation of knowledge about the effects of health interventions. We argue that patients should usually be required to contribute outcome data while using SAPs.

KW - special access

KW - patient rights

KW - health care delivery

KW - regulatory issues

KW - experimental therapies

KW - research ethics

KW - end-of-life issues

KW - terminally-ill patients

KW - therapeutic misconception

KW - compassionate use

KW - health-care

KW - off-label

KW - drugs

KW - discovery

KW - agents

U2 - 10.1080/15265161.2014.957416

DO - 10.1080/15265161.2014.957416

M3 - Article

VL - 14

SP - 3

EP - 15

JO - American Journal of Bioethics

JF - American Journal of Bioethics

SN - 1526-5161

IS - 11

ER -